Table 3.
HRs for diabetes complications and mortality of the diabetes patients with and without depressive disorder, total and stratified by types of depression, gender, age and duration between diagnosis and initiation of pharmacotherapy
Macro complication aHR (95% CI) |
Micro complication aHR (95% CI) |
DM-related death aHR (95% CI) |
Circulation death aHR (95% CI) |
Unnatural death aHR (95% CI) |
Suicide aHR (95% CI) |
All-cause mortality aHR (95% CI) |
|
---|---|---|---|---|---|---|---|
All samples | 1.35 (1.32–1.37) | 0.99 (0.97–1.02) | 0.86 (0.77–0.95) | 0.96 (0.88–1.06) | 2.59 (2.30–2.91) | 5.64 (4.70–6.77) | 1.08 (1.04–1.12) |
Types of depression | |||||||
MDD, recurrent | 1.44 (1.39–1.50) | 1.04 (0.99–1.09) | 1.08 (0.87–1.33) | 1.07 (0.88–1.30) | 4.52 (3.64–5.63) | 12.00 (8.31–17.31) | 1.19 (1.11–1.28) |
MDD, single | 1.38 (1.31–1.45) | 1.01 (0.95–1.07) | 0.99 (0.75–1.30) | 1.07 (0.85–1.35) | 3.10 (2.31–4.16) | 6.90 (4.43–10.73) | 1.18 (1.09–1.28) |
Dysthymia | 1.31 (1.27–1.35) | 0.97 (0.93–1.00) | 0.71 (0.61–0.84) | 0.91 (0.79–1.04) | 1.89 (1.58–2.27) | 3.26 (2.49–4.27) | 1.01 (0.96–1.06) |
Depressive disorder, NOS | 1.25 (1.17–1.34) | 0.97 (0.90–1.05) | 0.92 (0.66–1.29) | 0.85 (0.63–1.15) | 1.29 (0.82–2.02) | 4.80 (2.31–9.94) | 1.03 (0.92–1.14) |
Sex | |||||||
Male | 1.30 (1.26–1.34) | 0.99 (0.96–1.03) | 0.87 (0.75–1.02) | 0.94 (0.82–1.07) | 2.24 (1.92–2.62) | 4.76 (3.77–6.00) | 1.06 (1.01–1.11) |
Female | 1.38 (1.34–1.42) | 0.99 (0.96–1.02) | 0.85 (0.73–0.99) | 1.00 (0.87–1.14) | 3.23 (2.67–3.90) | 7.38 (5.48–9.95) | 1.11 (1.06–1.17) |
Sex × depression interaction | p-Value = 0.0017 | p-Value = 0.9997 | p-Value = 0.7069 | p-Value = 0.4888 | p-Value = 0.0015 | p-Value = 0.0118 | p-Value = 0.1745 |
Age | |||||||
20–44 | 1.51 (1.44–1.59) | 1.06 (1.01–1.11) | 1.22 (0.92–1.61) | 1.34 (1.00–1.81) | 4.00 (3.15–5.08) | 8.92 (6.19–12.85) | 1.35 (1.23–1.48) |
45–64 | 1.35 (1.31–1.39) | 0.98 (0.95–1.01) | 0.83 (0.70–0.99) | 0.92 (0.78–1.08) | 2.75 (2.33–3.25) | 5.29 (4.13–6.79) | 1.09 (1.03–1.15) |
⩾65 | 1.24 (1.19–1.29) | 0.96 (0.91–1.01) | 0.76 (0.64–0.90) | 0.93 (0.81–1.05) | 1.35 (1.04–1.76) | 3.33 (2.20–5.05) | 0.97 (0.92–1.02) |
Age × depression interaction (45–64 v. 20–44) (⩾65 v. 20–44) |
p-Value <0.0001 p-Value <0.0001 |
p-Value = 0.0003 p-Value = 0.0005 |
p-Value = 0.0002 p-Value <0.0001 |
p-Value = 0.0181 p-Value = 0.0079 |
p-Value = 0.0017 p-Value <0.0001 |
p-Value = 0.0070 p-Value = 0.0003 |
p-Value <0.0001 p-Value <0.0001 |
Duration between diagnosis and initiation of pharmacotherapy | |||||||
<1 year | 1.34 (1.31–1.37) | 0.97 (0.95–1.00) | 0.81 (0.72–0.92) | 0.92 (0.83–1.03) | 0.92 (0.83–1.03) | 5.45 (4.48–6.62) | 1.05 (1.01–1.09) |
≧1 year | 1.36 (1.30–1.42) | 1.06 (1.01–1.12) | 1.07 (0.84–1.36) | 1.16 (0.94–1.45) | 1.16 (0.94–1.45) | 7.06 (4.22–11.79) | 1.20 (1.11–1.29) |
Duration × depression interaction | p-Value = 0.7812 | p-Value = 0.0013 | p-Value = 0.0218 | p-Value = 0.0839 | p-Value = 0.5794 | p-Value = 0.4134 | p-Value = 0.0046 |
MDD, major depressive disorder; NOS, not otherwise specified.